Does Cardiac-Resynchronization Therapy reduce the rate of death or hospitalization for heart failure in patients with systolic heart failure and a QRS duration of less than 130 msec?
Patients with systolic heart failure and a QRS duration of less than 130 msec
Cardiac-Resynchronization Therapy (CRT)
Rate of death or hospitalization for heart failurecomposite
In patients with systolic heart failure and a narrow QRS complex (<130 msec), CRT does not improve clinical outcomes and may increase mortality, indicating it should be avoided in this population.
In patients with systolic heart failure and a QRS duration of less than 130 msec, CRT does not reduce the rate of death or hospitalization for heart failure and may increase mortality. (Funded by Biotronik and GE Healthcare; EchoCRT ClinicalTrials.gov number, NCT00683696.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Frank Ruschitzka
Heart Failure & Transplant
William T. Abraham
Heart Failure & Transplant
G. André Ng
Boston University
New England Journal of Medicine
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
Harvard University
Massachusetts General Hospital
University of Glasgow
Building similarity graph...
Analyzing shared references across papers
Loading...
Ruschitzka et al. (Tue,) studied this question.
synapsesocial.com/papers/69d575356e4506aa303c1449 — DOI: https://doi.org/10.1056/nejmoa1306687
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: